Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Bone metastasis is the third most common condition in metastatic cancers and occurs in 60-65% of patients with metastatic cancers. The spine is the most common site of bone metastasis. Other common sites include ribs, skull, pelvis (hip bone), femur (leg bone) and humerus (arm bone). Bone metastatic cancers are rarely able to be cured, and treatment of bone metastasis involves medications to shrink, stop or slow down the growth of the tumor. Treatment options available for bone metastasis are symptomatic treatments which are meant for pain control, treatment, and prevention of fractures, improvement in functional disability, etc. Randomized trials on metastatic patients by UBM Medica, LLC showed that 45-75% patients develop functional disability every 3-4 months, 10-15% patients develop hypercalcemia and 10-20% patients develop long bone fractures.
Treatment of bone metastasis is the interdisciplinary field involving pain management, orthopedics, and other medical specialties. Primary factors driving the growth of bone metastasis therapeutics market are the global increase in cancer prevalence and delayed diagnosis of cancer in low-income countries. According to University of Texas Southwestern Medical Center Dallas, over 600,000 of bone metastasis are diagnosed in the U.S. every year. Rapid innovation in the field of personalized medicine and identification of new therapeutic targets for bone metastasis presents a huge opportunity to manufacturers of targeted therapy agents. A large number of treatment methods are still under investigation. However, heterogeneous nature of cancer and high development cost of neoplastic agents are the factors limiting the growth of global bone metastasis therapeutics market.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Bone Metastasis Therapeutics market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Bone Metastasis Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Bone Metastasis Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Merck
Bayer
F Hoffmann-La Roche
By Type:
Drug Treatment
Tumor Ablation Therapy
Surgery
By End-User:
Hospitals
Cancer Rehabilitation Centers
Specialty Clinics
Ambulatory Surgical Centers
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Bone Metastasis Therapeutics Market
-
1.3 Market Segment by Type
-
1.3.1 China Bone Metastasis Therapeutics Market Size and Growth Rate of Drug Treatment from 2016 to 2027
-
1.3.2 China Bone Metastasis Therapeutics Market Size and Growth Rate of Tumor Ablation Therapy from 2016 to 2027
-
1.3.3 China Bone Metastasis Therapeutics Market Size and Growth Rate of Surgery from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Bone Metastasis Therapeutics Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 China Bone Metastasis Therapeutics Market Size and Growth Rate of Cancer Rehabilitation Centers from 2016 to 2027
-
1.4.3 China Bone Metastasis Therapeutics Market Size and Growth Rate of Specialty Clinics from 2016 to 2027
-
1.4.4 China Bone Metastasis Therapeutics Market Size and Growth Rate of Ambulatory Surgical Centers from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Bone Metastasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Bone Metastasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Bone Metastasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Bone Metastasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Bone Metastasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Bone Metastasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Bone Metastasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Bone Metastasis Therapeutics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Bone Metastasis Therapeutics by Major Types
-
3.4.1 Market Size and Growth Rate of Drug Treatment
-
3.4.2 Market Size and Growth Rate of Tumor Ablation Therapy
-
3.4.3 Market Size and Growth Rate of Surgery
4 Segmentation of Bone Metastasis Therapeutics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Bone Metastasis Therapeutics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Bone Metastasis Therapeutics in Hospitals
-
4.4.2 Market Size and Growth Rate of Bone Metastasis Therapeutics in Cancer Rehabilitation Centers
-
4.4.3 Market Size and Growth Rate of Bone Metastasis Therapeutics in Specialty Clinics
-
4.4.4 Market Size and Growth Rate of Bone Metastasis Therapeutics in Ambulatory Surgical Centers
5 Market Analysis by Regions
-
5.1 China Bone Metastasis Therapeutics Production Analysis by Regions
-
5.2 China Bone Metastasis Therapeutics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Bone Metastasis Therapeutics Landscape Analysis
-
6.1 North China Bone Metastasis Therapeutics Landscape Analysis by Major Types
-
6.2 North China Bone Metastasis Therapeutics Landscape Analysis by Major End-Users
7 Central China Bone Metastasis Therapeutics Landscape Analysis
-
7.1 Central China Bone Metastasis Therapeutics Landscape Analysis by Major Types
-
7.2 Central China Bone Metastasis Therapeutics Landscape Analysis by Major End-Users
8 South China Bone Metastasis Therapeutics Landscape Analysis
-
8.1 South China Bone Metastasis Therapeutics Landscape Analysis by Major Types
-
8.2 South China Bone Metastasis Therapeutics Landscape Analysis by Major End-Users
9 East China Bone Metastasis Therapeutics Landscape Analysis
-
9.1 East China Bone Metastasis Therapeutics Landscape Analysis by Major Types
-
9.2 East China Bone Metastasis Therapeutics Landscape Analysis by Major End-Users
10 Northeast China Bone Metastasis Therapeutics Landscape Analysis
-
10.1 Northeast China Bone Metastasis Therapeutics Landscape Analysis by Major Types
-
10.2 Northeast China Bone Metastasis Therapeutics Landscape Analysis by Major End-Users
11 Southwest China Bone Metastasis Therapeutics Landscape Analysis
-
11.1 Southwest China Bone Metastasis Therapeutics Landscape Analysis by Major Types
-
11.2 Southwest China Bone Metastasis Therapeutics Landscape Analysis by Major End-Users
12 Northwest China Bone Metastasis Therapeutics Landscape Analysis
-
12.1 Northwest China Bone Metastasis Therapeutics Landscape Analysis by Major Types
-
12.2 Northwest China Bone Metastasis Therapeutics Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Merck
-
13.1.1 Merck Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Bayer
-
13.2.1 Bayer Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 F Hoffmann-La Roche
-
13.3.1 F Hoffmann-La Roche Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Bone Metastasis Therapeutics Market Size and Growth Rate of Drug Treatment from 2016 to 2027
-
Figure China Bone Metastasis Therapeutics Market Size and Growth Rate of Tumor Ablation Therapy from 2016 to 2027
-
Figure China Bone Metastasis Therapeutics Market Size and Growth Rate of Surgery from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Bone Metastasis Therapeutics Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure China Bone Metastasis Therapeutics Market Size and Growth Rate of Cancer Rehabilitation Centers from 2016 to 2027
-
Figure China Bone Metastasis Therapeutics Market Size and Growth Rate of Specialty Clinics from 2016 to 2027
-
Figure China Bone Metastasis Therapeutics Market Size and Growth Rate of Ambulatory Surgical Centers from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Bone Metastasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Bone Metastasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Bone Metastasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Bone Metastasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Bone Metastasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Bone Metastasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Bone Metastasis Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Bone Metastasis Therapeutics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Bone Metastasis Therapeutics
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Bone Metastasis Therapeutics by Different Types from 2016 to 2027
-
Table Consumption Share of Bone Metastasis Therapeutics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Drug Treatment
-
Figure Market Size and Growth Rate of Tumor Ablation Therapy
-
Figure Market Size and Growth Rate of Surgery
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Bone Metastasis Therapeutics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Bone Metastasis Therapeutics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Cancer Rehabilitation Centers
-
Figure Market Size and Growth Rate of Specialty Clinics
-
Figure Market Size and Growth Rate of Ambulatory Surgical Centers
-
Table China Bone Metastasis Therapeutics Production by Regions
-
Table China Bone Metastasis Therapeutics Production Share by Regions
-
Figure China Bone Metastasis Therapeutics Production Share by Regions in 2016
-
Figure China Bone Metastasis Therapeutics Production Share by Regions in 2021
-
Figure China Bone Metastasis Therapeutics Production Share by Regions in 2027
-
Table China Bone Metastasis Therapeutics Consumption by Regions
-
Table China Bone Metastasis Therapeutics Consumption Share by Regions
-
Figure China Bone Metastasis Therapeutics Consumption Share by Regions in 2016
-
Figure China Bone Metastasis Therapeutics Consumption Share by Regions in 2021
-
Figure China Bone Metastasis Therapeutics Consumption Share by Regions in 2027
-
Table North China Bone Metastasis Therapeutics Consumption by Types from 2016 to 2027
-
Table North China Bone Metastasis Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure North China Bone Metastasis Therapeutics Consumption Share by Types in 2016
-
Figure North China Bone Metastasis Therapeutics Consumption Share by Types in 2021
-
Figure North China Bone Metastasis Therapeutics Consumption Share by Types in 2027
-
Table North China Bone Metastasis Therapeutics Consumption by End-Users from 2016 to 2027
-
Table North China Bone Metastasis Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure North China Bone Metastasis Therapeutics Consumption Share by End-Users in 2016
-
Figure North China Bone Metastasis Therapeutics Consumption Share by End-Users in 2021
-
Figure North China Bone Metastasis Therapeutics Consumption Share by End-Users in 2027
-
Table Central China Bone Metastasis Therapeutics Consumption by Types from 2016 to 2027
-
Table Central China Bone Metastasis Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Central China Bone Metastasis Therapeutics Consumption Share by Types in 2016
-
Figure Central China Bone Metastasis Therapeutics Consumption Share by Types in 2021
-
Figure Central China Bone Metastasis Therapeutics Consumption Share by Types in 2027
-
Table Central China Bone Metastasis Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Central China Bone Metastasis Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Bone Metastasis Therapeutics Consumption Share by End-Users in 2016
-
Figure Central China Bone Metastasis Therapeutics Consumption Share by End-Users in 2021
-
Figure Central China Bone Metastasis Therapeutics Consumption Share by End-Users in 2027
-
Table South China Bone Metastasis Therapeutics Consumption by Types from 2016 to 2027
-
Table South China Bone Metastasis Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure South China Bone Metastasis Therapeutics Consumption Share by Types in 2016
-
Figure South China Bone Metastasis Therapeutics Consumption Share by Types in 2021
-
Figure South China Bone Metastasis Therapeutics Consumption Share by Types in 2027
-
Table South China Bone Metastasis Therapeutics Consumption by End-Users from 2016 to 2027
-
Table South China Bone Metastasis Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure South China Bone Metastasis Therapeutics Consumption Share by End-Users in 2016
-
Figure South China Bone Metastasis Therapeutics Consumption Share by End-Users in 2021
-
Figure South China Bone Metastasis Therapeutics Consumption Share by End-Users in 2027
-
Table East China Bone Metastasis Therapeutics Consumption by Types from 2016 to 2027
-
Table East China Bone Metastasis Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure East China Bone Metastasis Therapeutics Consumption Share by Types in 2016
-
Figure East China Bone Metastasis Therapeutics Consumption Share by Types in 2021
-
Figure East China Bone Metastasis Therapeutics Consumption Share by Types in 2027
-
Table East China Bone Metastasis Therapeutics Consumption by End-Users from 2016 to 2027
-
Table East China Bone Metastasis Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure East China Bone Metastasis Therapeutics Consumption Share by End-Users in 2016
-
Figure East China Bone Metastasis Therapeutics Consumption Share by End-Users in 2021
-
Figure East China Bone Metastasis Therapeutics Consumption Share by End-Users in 2027
-
Table Northeast China Bone Metastasis Therapeutics Consumption by Types from 2016 to 2027
-
Table Northeast China Bone Metastasis Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Bone Metastasis Therapeutics Consumption Share by Types in 2016
-
Figure Northeast China Bone Metastasis Therapeutics Consumption Share by Types in 2021
-
Figure Northeast China Bone Metastasis Therapeutics Consumption Share by Types in 2027
-
Table Northeast China Bone Metastasis Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northeast China Bone Metastasis Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Bone Metastasis Therapeutics Consumption Share by End-Users in 2016
-
Figure Northeast China Bone Metastasis Therapeutics Consumption Share by End-Users in 2021
-
Figure Northeast China Bone Metastasis Therapeutics Consumption Share by End-Users in 2027
-
Table Southwest China Bone Metastasis Therapeutics Consumption by Types from 2016 to 2027
-
Table Southwest China Bone Metastasis Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Bone Metastasis Therapeutics Consumption Share by Types in 2016
-
Figure Southwest China Bone Metastasis Therapeutics Consumption Share by Types in 2021
-
Figure Southwest China Bone Metastasis Therapeutics Consumption Share by Types in 2027
-
Table Southwest China Bone Metastasis Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Southwest China Bone Metastasis Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Bone Metastasis Therapeutics Consumption Share by End-Users in 2016
-
Figure Southwest China Bone Metastasis Therapeutics Consumption Share by End-Users in 2021
-
Figure Southwest China Bone Metastasis Therapeutics Consumption Share by End-Users in 2027
-
Table Northwest China Bone Metastasis Therapeutics Consumption by Types from 2016 to 2027
-
Table Northwest China Bone Metastasis Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Bone Metastasis Therapeutics Consumption Share by Types in 2016
-
Figure Northwest China Bone Metastasis Therapeutics Consumption Share by Types in 2021
-
Figure Northwest China Bone Metastasis Therapeutics Consumption Share by Types in 2027
-
Table Northwest China Bone Metastasis Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northwest China Bone Metastasis Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Bone Metastasis Therapeutics Consumption Share by End-Users in 2016
-
Figure Northwest China Bone Metastasis Therapeutics Consumption Share by End-Users in 2021
-
Figure Northwest China Bone Metastasis Therapeutics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of F Hoffmann-La Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche
-
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche
-
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche
-
Table Product and Service Introduction of F Hoffmann-La Roche
-
